Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-04

Clinical Trial Update: Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) [Phase 3]

View source ↗

Summary

Phase 3 trial ADJUPANC comparing adjuvant chemoradiotherapy versus chemotherapy for pancreatic cancer is currently recruiting, sponsored by Changhai Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Cancer | Phase 3 | Status: RECRUITING